RS
CYTK icon

Rakuten Securities’s Cytokinetics CYTK Stock Holding History

Rakuten Securities’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-170
Closed -$11.2K – 942
2026
Q1 		$11.2K Buy
170
+120
+240% +$7.63K ﹤0.01% 410
2025
Q4 		$3.18K Buy
+50
New +$3.11K ﹤0.01% 574

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rakuten Securities's CYTK Position: Q2 2026 in Review

Rakuten Securities sold out of Cytokinetics (CYTK) in Q2 2026, closing a stake of 170 shares — an estimated $11.2K sold.

Rakuten Securities first reported a position in CYTK in Q4 2025 and held it in 2 quarters. The position peaked at $11.2K in Q1 2026. 483 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Rakuten Securities reported no remaining Cytokinetics position as of Q2 2026 after selling out during the quarter.
  • Rakuten Securities sold 170 Cytokinetics shares in Q2 2026, an estimated $11.2K.
  • Rakuten Securities first reported a position in Cytokinetics in Q4 2025 and held it in 2 quarters.
  • Rakuten Securities's Cytokinetics position peaked at $11.2K in Q1 2026.
  • 483 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.